Horizon Pharma (HZNP)

Add to Watchlists
Create an Alert
13.37 +0.19  +1.44% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
HZNP Price Chart
View All Events

HZNP Events

Date Type Description
Mar 19 Misc Horizon Pharma to Acquire Vidara Therapeutics International Ltd. And Become Horizon Pharma Plc
Mar 13 Misc Q4 2013 Horizon Pharma Earnings Call
Mar 13 Earnings Q4 2013 Horizon Pharma Earnings Results. Estimate: -0.06.
Nov 19 Misc Horizon Pharma Conference Call
Nov 19 Misc Horizon Pharma Announces Agreement to Acquire u.s. Rights to Vimovo(r) and Provides 2014 Guidance
Nov 08 Misc Horizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2013 Financial Results on November 8, 2013
Nov 08 Earnings Horizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2013 Financial Results. Estimate: -0.29.
Aug 09 Misc Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2013 Financial Results on August 9, 2013
Aug 09 Earnings Second Quarter 2013 Earnings Results. Estimate: -0.31.
May 31 Misc AGM Event for Horizon Pharma Inc
View All Performance Charts

HZNP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Horizon Pharma is up 489.0% over the last year vs S&P 500 Total Return up 23.54%, Sanofi up 2.20%, and Forest Laboratories up 151.7%.

Get Quote for

PDF Report for HZNP

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download HZNP Pro Report PDF
Advertisement

Portfolio Strategies Featuring HZNP

Did Horizon Pharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

HZNP Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Illinois
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Horizon Pharma Inc is a specialty pharmaceutical company. It has developed and is commercializing DUEXIS, VIMOVO and RAYOS/LODOTRA, each of which targets unmet therapeutic needs in arthritis, pain and inflammatory diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
HZNP 13.37 +0.19 +1.44% 905.60M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.